EDMA (European Diagnostic Manufacturers Association) concern at low IVD (in vitro diagnostic) use
This article was originally published in Clinica
Executive Summary
"European spending on in vitro diagnostics is clearly too low," says the European Diagnostic Manufacturers Association (EDMA) in notes accompanying its recently published 2000 annual audit. Short-term cost-cutting has been the motive, but health systems must prepare to respond to the longer term rise in demand for in vitro testing, says the Brussels-based association.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.